These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8540595

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL, Curtis GC, Cameron OG.
    J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL, Khan S, Liberzon I, Young EA.
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
    Curtis GC, Abelson JL, Gold PW.
    Biol Psychiatry; 1997 Jan 01; 41(1):76-85. PubMed ID: 8988798
    [Abstract] [Full Text] [Related]

  • 7. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ.
    Psychiatr Danub; 2015 Sep 01; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis.
    Dekkers JC, Geenen R, Godaert GL, Glaudemans KA, Lafeber FP, van Doornen LJ, Bijlsma JW.
    J Rheumatol; 2001 Jul 01; 28(7):1496-504. PubMed ID: 11469453
    [Abstract] [Full Text] [Related]

  • 13. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS, Coplan JD, Pine DS, Martinez JA, Klein DF, Gorman JM.
    Psychiatry Res; 1999 May 31; 86(2):93-8. PubMed ID: 10397411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.
    Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME.
    Neuropsychopharmacology; 2006 Nov 31; 31(11):2515-22. PubMed ID: 16841071
    [Abstract] [Full Text] [Related]

  • 16. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC, Sharifi N, Condren R, Thakore JH.
    Psychoneuroendocrinology; 2004 Sep 31; 29(8):1065-70. PubMed ID: 15219658
    [Abstract] [Full Text] [Related]

  • 17. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May 31; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 18. Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients.
    Ronchi CL, Ferrante E, Rizzo E, Giavoli C, Verrua E, Bergamaschi S, Lania AG, Beck-Peccoz P, Spada A.
    Clin Endocrinol (Oxf); 2008 Oct 31; 69(4):608-12. PubMed ID: 18410544
    [Abstract] [Full Text] [Related]

  • 19. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Oct 31; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 20. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM, Mullen BC, Schatzberg AF.
    Psychoneuroendocrinology; 2007 Oct 31; 32(8-10):859-64. PubMed ID: 17666187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.